NeoGenomics (NEO) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Join SI Premium – FREE
NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $22.43 million.
For earnings history and earnings-related data on NeoGenomics (NEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
